130 related articles for article (PubMed ID: 8822842)
1. Sulfa resistance in mouse-derived Pneumocystis carinii.
Lane B; Hossler P; Bartlett M; Queener S; O'Reilly T; Smith J; Meshnick S
J Eukaryot Microbiol; 1996; 43(5):39S. PubMed ID: 8822842
[No Abstract] [Full Text] [Related]
2. Relationship between mutations in dihydropteroate synthase of Pneumocystis carinii f. sp. hominis isolates in Japan and resistance to sulfonamide therapy.
Takahashi T; Hosoya N; Endo T; Nakamura T; Sakashita H; Kimura K; Ohnishi K; Nakamura Y; Iwamoto A
J Clin Microbiol; 2000 Sep; 38(9):3161-4. PubMed ID: 10970350
[TBL] [Abstract][Full Text] [Related]
3. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use.
Ma L; Borio L; Masur H; Kovacs JA
J Infect Dis; 1999 Dec; 180(6):1969-78. PubMed ID: 10558954
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of sulfa drugs against recombinant Pneumocystis carinii dihydropteroate synthetase and in vivo.
Hong YL; Hossler P; Bartlett M; Queener S; Smith J; Meshnick S
J Eukaryot Microbiol; 1996; 43(5):40S. PubMed ID: 8822843
[No Abstract] [Full Text] [Related]
5. Absence of mutations associated with sulfa resistance in Pneumocystis carinii dihydropteroate synthase gene from non-human primates.
Demanche C; Guillot J; Berthelemy M; Petitt T; Roux P; Wakefield AE
Med Mycol; 2002 Jun; 40(3):315-8. PubMed ID: 12146763
[TBL] [Abstract][Full Text] [Related]
6. Pneumocystis carinii dihydropteroate synthase mutations and treatment with sulfa or sulfone regimens: a proposal for standardized definitions for clinical evaluation.
Huang L; Morris AM; Beard CB
J Eukaryot Microbiol; 2001; Suppl():180S-181S. PubMed ID: 11906054
[No Abstract] [Full Text] [Related]
7. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients.
Kazanjian P; Locke AB; Hossler PA; Lane BR; Bartlett MS; Smith JW; Cannon M; Meshnick SR
AIDS; 1998 May; 12(8):873-8. PubMed ID: 9631140
[TBL] [Abstract][Full Text] [Related]
8. Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance.
Huang L; Crothers K; Atzori C; Benfield T; Miller R; Rabodonirina M; Helweg-Larsen J
Emerg Infect Dis; 2004 Oct; 10(10):1721-8. PubMed ID: 15504256
[TBL] [Abstract][Full Text] [Related]
9. High Prevalence of Pneumocystis jirovecii Dihydropteroate Synthase Gene Mutations in Patients with a First Episode of Pneumocystis Pneumonia in Santiago, Chile, and Clinical Response to Trimethoprim-Sulfamethoxazole Therapy.
Ponce CA; Chabé M; George C; Cárdenas A; Durán L; Guerrero J; Bustamante R; Matos O; Huang L; Miller RF; Vargas SL
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855071
[TBL] [Abstract][Full Text] [Related]
10. Absence of dihydropteroate synthase mutations in Pneumocystis jirovecii from Brazilian AIDS patients.
Wissmann G; Alvarez-Martinez MJ; Meshnick SR; Dihel AR; Prolla JC
J Eukaryot Microbiol; 2006; 53(4):305-7. PubMed ID: 16872298
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of recombinant Pneumocystis carinii dihydropteroate synthetase by sulfa drugs.
Hong YL; Hossler PA; Calhoun DH; Meshnick SR
Antimicrob Agents Chemother; 1995 Aug; 39(8):1756-63. PubMed ID: 7486915
[TBL] [Abstract][Full Text] [Related]
12. Drug-resistant Pneumocystis carinii.
Meshnick SR
Lancet; 1999 Oct; 354(9187):1318-9. PubMed ID: 10533856
[No Abstract] [Full Text] [Related]
13. Failure of co-trimoxazole in Pneumocystis carinii infection and mutations in dihydropteroate synthase gene.
Mei Q; Gurunathan S; Masur H; Kovacs JA
Lancet; 1998 May; 351(9116):1631-2. PubMed ID: 9620722
[No Abstract] [Full Text] [Related]
14. Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P carinii pneumonia in patients with HIV-1: a prospective study.
Navin TR; Beard CB; Huang L; del Rio C; Lee S; Pieniazek NJ; Carter JL; Le T; Hightower A; Rimland D
Lancet; 2001 Aug; 358(9281):545-9. PubMed ID: 11520525
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Pneumocystis carinii pneumonia with 1,3-beta-glucan synthesis inhibitors.
Schmatz DM; Romancheck MA; Pittarelli LA; Schwartz RE; Fromtling RA; Nollstadt KH; Vanmiddlesworth FL; Wilson KE; Turner MJ
Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5950-4. PubMed ID: 2198575
[TBL] [Abstract][Full Text] [Related]
16. Identification of a class of sulfonamides highly active against dihydropteroate synthase form Toxoplasma gondii, Pneumocystis carinii, and Mycobacterium avium.
Chio LC; Bolyard LA; Nasr M; Queener SF
Antimicrob Agents Chemother; 1996 Mar; 40(3):727-33. PubMed ID: 8851601
[TBL] [Abstract][Full Text] [Related]
17. Sulfa resistance and dihydropteroate synthase mutants in recurrent Pneumocystis carinii pneumonia.
Nahimana A; Rabodonirina M; Helweg-Larsen J; Meneau I; Francioli P; Bille J; Hauser PM
Emerg Infect Dis; 2003 Jul; 9(7):864-7. PubMed ID: 12890330
[TBL] [Abstract][Full Text] [Related]
18. Dihydrofolate reductase gene polymorphisms in Pneumocystis carinii f. sp. hominis in Japan.
Takahashi T; Endo T; Nakamura T; Sakashita H; Kimura K; Ohnishi K; Kitamura Y; Iwamoto A
J Med Microbiol; 2002 Jun; 51(6):510-515. PubMed ID: 12018659
[TBL] [Abstract][Full Text] [Related]
19. Mutations in the dihydropteroate synthase gene of human-derived Pneumocystis carinii isolates from Italy are infrequent but correlate with prior sulfa prophylaxis.
Ma L; Kovacs JA; Cargnel A; Valerio A; Fantoni G; Atzori C
J Infect Dis; 2002 May; 185(10):1530-2. PubMed ID: 11992293
[TBL] [Abstract][Full Text] [Related]
20. PCR-RFLP analysis of the DHPS gene for the study of resistance of Pneumocystis carinii to sulpha drugs in patients with co-infection PCP/HIV.
Costa MC; Helweg-Larsen J; Antunes F; Lungren B; Diogo J; Matos O
J Eukaryot Microbiol; 2001; Suppl():148S-149S. PubMed ID: 11906035
[No Abstract] [Full Text] [Related]
[Next] [New Search]